Cargando…
shRNA targeting PLK1 inhibits the proliferation and invasion of nasopharyngeal carcinoma cells
BACKGROUND: Polo-like kinase 1 (PLK1) is a serine/threonine protein kinase, which has been studied as a potential gene therapy target for many years. PLK1 is overexpressed in a variety of tumors, and its expression often negatively correlated with patient prognosis. However, the role of PLK1 in naso...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798612/ https://www.ncbi.nlm.nih.gov/pubmed/35117900 http://dx.doi.org/10.21037/tcr-20-811 |